NeuBase Therapeutics Inc

NBSE

$10.08

+8.22% (1 year change)

Avg closing price

Price range

Market Cap

$195 Million

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

Revenue

-

Total revenue in the last quarter.

Net Income

-

Net income is all revenues minus all expenses including taxes and interest in the last quarter.

Earnings per Share

$0.00

Earnings per share is the amount of net income that is attributed to each single share outstanding.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Price-Earnings Ratio

0.0x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

EBIT

-

Earnings before interest expenses and taxes in the last quarter.

Employees

0

The number of full time employees.

Revenue & Earnings

Balance Sheet

NeuBase Therapeutics Inc

News

David Einhorn — Notorious Tesla Short Seller — Just Had His Best Quarter Ever

David Einhorn — Notorious Tesla Short Seller — Just Had His Best Quarter Ever

Greenlight Capital hedge fund manager and notorious value investor David Einhorn just released his annual letter to investors, which revealed a record quarter for Einhorn to close out a difficult 2...

Benzinga Benzinga, 4 days ago
OHR Pharmaceutical (NASDAQ:OHRP) Stock Price Passes Above 50-Day Moving Average of $8.19

OHR Pharmaceutical (NASDAQ:OHRP) Stock Price Passes Above 50-Day Moving Average of $8.19

Shares of OHR Pharmaceutical Inc (NASDAQ:OHRP) crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $8.19 and traded as high as $8.95. OHR P...

US Banking News US Banking News, 3 months ago
The Daily Biotech Pulse: Tiziana Snags A Patent Win, Decision Day For Nabriva And Evoke, IPOs

The Daily Biotech Pulse: Tiziana Snags A Patent Win, Decision Day For Nabriva And Evoke, IPOs

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 18) ADC Therapeutics SA (NYSE: ADCT ) Adverum Biotechn...

Benzinga Benzinga, 7 months ago